Literature DB >> 2959719

Inhibiting effect of cetirizine on histamine-induced and 48/80-induced wheals and flares, experimental dermographism, and cold-induced urticaria.

L Juhlin1, C de Vos, J P Rihoux.   

Abstract

A single oral dose of cetirizine, 10 mg, a new H1 antagonist with minimal sedative effects and devoid of anticholinergic activities, was administered to eight healthy subjects. It markedly inhibited the wheal and flare induced 4 hours later by intracutaneously injected histamine and compound 48/80. Dermographism was produced by different pressures (100 to 500 gm/15 mm2) in 10 patients with factitial urticaria. Four hours after 10 mg of cetirizine, the whealing was absent in eight patients and markedly reduced in the other two subjects. In 12 patients with cold urticaria, wheals were induced by 30 seconds to 12 minutes application of an ice cube. Four hours after 10 mg of cetirizine, the urticarial reaction had disappeared in five patients and was decreased in the other patients. No itching was experienced in any of the patients after cetirizine, but the tested areas had an erythema lasting for 20 to 60 minutes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2959719     DOI: 10.1016/0091-6749(87)90014-5

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  10 in total

1.  The effect of 2 weeks treatment with cetirizine on bronchial reactivity to methacholine in asthma.

Authors:  J P Finnerty; S T Holgate; J P Rihoux
Journal:  Br J Clin Pharmacol       Date:  1990-01       Impact factor: 4.335

2.  Modern approaches to the diagnosis and treatment of cold contact urticaria.

Authors:  Karoline Krause; Torsten Zuberbier; Marcus Maurer
Journal:  Curr Allergy Asthma Rep       Date:  2010-07       Impact factor: 4.806

Review 3.  Pharmacokinetic optimisation of histamine H1-receptor antagonist therapy.

Authors:  F E Simons; K J Simons
Journal:  Clin Pharmacokinet       Date:  1991-11       Impact factor: 6.447

Review 4.  Clinical pharmacology of new histamine H1 receptor antagonists.

Authors:  F E Simons; K J Simons
Journal:  Clin Pharmacokinet       Date:  1999-05       Impact factor: 6.447

5.  [Cold-induced urticaria and angioedema. Classification, diagnosis and therapy].

Authors:  K Krause; F Degener; S Altrichter; E Ardelean; D Kalogeromitros; M Magerl; M Metz; F Siebenhaar; K Weller; M Maurer
Journal:  Hautarzt       Date:  2010-09       Impact factor: 0.751

6.  Cetirizine: a review of its use in allergic disorders.

Authors:  Monique P Curran; Lesley J Scott; Caroline M Perry
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 7.  Cetirizine. A review of its pharmacological properties and clinical potential in allergic rhinitis, pollen-induced asthma, and chronic urticaria.

Authors:  D M Campoli-Richards; M M Buckley; A Fitton
Journal:  Drugs       Date:  1990-11       Impact factor: 9.546

8.  Inhibition of histamine-induced nasal obstruction by cetirizine in allergic rhinitis.

Authors:  G Braunstein; F Malaquin; I Fajac; M Melac; N Frossard
Journal:  Br J Clin Pharmacol       Date:  1992-04       Impact factor: 4.335

Review 9.  Urticaria. Recognition, causes and treatment.

Authors:  A D Ormerod
Journal:  Drugs       Date:  1994-11       Impact factor: 9.546

10.  In vitro effect of cetirizine on PGE2 release by rat peritoneal macrophages and human monocytes.

Authors:  M Roch-Arveiller; M Tissot; N Idohou; G Sarfati; J P Giroud; D Raichvarg
Journal:  Agents Actions       Date:  1994-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.